TB Medicine Pretomanid Enters Regulatory Review Process in the United States
NEW YORK, NY (March 8, 2019)—TB Alliance’s new drug application (NDA) for the novel tuberculosis (TB) drug candidate pretomanid has
NEW YORK, NY (March 8, 2019)—TB Alliance’s new drug application (NDA) for the novel tuberculosis (TB) drug candidate pretomanid has
NEW YORK (February 5, 2019) – TB Alliance applauds the Wellcome Trust’s commitment of over £10 million to the Drugs
Please note: this article discusses a major plot point of Red Dead Redemption 2 For players of Red Dead Redemption
NEW YORK (January 15, 2019)—TB Alliance, a not-for-profit organization dedicated to developing new drug regimens to fight tuberculosis (TB), has
December 4, 2018 – NEW YORK – Though global funding for tuberculosis (TB) research is beginning to move in the
[November 28, 2018, WASHINGTON, D.C.] – TB Alliance and partners were honored today as the winner of the Global Health
Project Syndicate Op-Ed by Willo Brock, SVP External Affairs, TB Alliance NEW YORK – In the 25 years since tuberculosis
November 19, 2018 – NEW YORK – TB Alliance congratulates DNDi and its partners on receiving a positive scientific opinion of
[October 24, 2018, NEW YORK] – TB Alliance has joined the Innovative Medicines Initiative (IMI) as an Associated Partner on
NEW YORK (September 26, 2018) It has been 25 years since tuberculosis (TB) was declared a global emergency by the World